Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay S Cohen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|July 18, 2003
Statins and low-density lipoprotein cholesterol levelsJay S Cohen
The Annals of Pharmacotherapy|February 19, 2002
High-dose oral magnesium treatment of chronic, intractable erythromelalgiaJay S Cohen
Journal of the American Medical Women'S Association (1972)|May 7, 2002
Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?Jay S Cohen
Lancet (London, England)|November 3, 2004
Should rosuvastatin be withdrawn from the market?Jay S Cohen
Archives of Dermatology|November 23, 2006
Transdermal therapy for erythromelalgiaJay S Cohen
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 3, 2002
Tablet splitting: imperfect perhaps, but better than excessive dosingJay S Cohen
The Annals of Pharmacotherapy|August 4, 2005
How celecoxib could be safer, how valdecoxib might have beenJay S Cohen
The Annals of Pharmacotherapy|September 2, 2004
Antidepressants: an avoidable and solvable controversyJay S Cohen
The Annals of Pharmacotherapy|December 31, 2002
Why aren't lower, effective, OTC doses available earlier by prescription?Jay S Cohen
The New England Journal of Medicine|December 1, 2006
Statin therapy after stroke or transient ischemic attackJay S Cohen
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|July 18, 2003
Statins and low-density lipoprotein cholesterol levelsJay S Cohen
The Annals of Pharmacotherapy|February 19, 2002
High-dose oral magnesium treatment of chronic, intractable erythromelalgiaJay S Cohen
Journal of the American Medical Women'S Association (1972)|May 7, 2002
Do standard doses of frequently prescribed drugs cause preventable adverse effects in women?Jay S Cohen
Lancet (London, England)|November 3, 2004
Should rosuvastatin be withdrawn from the market?Jay S Cohen
Archives of Dermatology|November 23, 2006
Transdermal therapy for erythromelalgiaJay S Cohen
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|April 3, 2002
Tablet splitting: imperfect perhaps, but better than excessive dosingJay S Cohen
The Annals of Pharmacotherapy|August 4, 2005
How celecoxib could be safer, how valdecoxib might have beenJay S Cohen
The Annals of Pharmacotherapy|September 2, 2004
Antidepressants: an avoidable and solvable controversyJay S Cohen
The Annals of Pharmacotherapy|December 31, 2002
Why aren't lower, effective, OTC doses available earlier by prescription?Jay S Cohen
The New England Journal of Medicine|December 1, 2006
Statin therapy after stroke or transient ischemic attackJay S Cohen
Pageof 2